Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands

Publisher： John Wiley & Sons Inc

E-ISSN： 1747-0285|91|1|181-193

ISSN： 1747-0277

Source： CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.91, Iss.1, 2018-01, pp. : 181-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis

By Mlost Jakub   Kostrzewa Magdalena   Malek Natalia   Starowicz Katarzyna  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 342-342

MDPI

Access to resources Recommend Favorite

Novel Oxazolidinone Antibacterial Analogues with a Substituted Ligustrazine C‐ring Unit

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 1747-0277, Iss. 4, 2015-10 ,pp. : 682-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Oxazolidinone Antibacterial Analogues with a Substituted Ligustrazine C‐ring Unit

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 4, 2015-10 ,pp. : 682-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 91, Iss. 2, 2018-02 ,pp. : 552-566

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hydroxytyrosol Inhibits Cannabinoid CB1 Receptor Gene Expression in 3T3‐L1 Preadipocyte Cell Line

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 231, Iss. 2, 2016-02 ,pp. : 483-489

John Wiley & Sons Inc

Access to resources Recommend Favorite